Home/Filings/4/0001209191-21-056482
4//SEC Filing

Prokupets Elena 4

Accession 0001209191-21-056482

CIK 0001662579other

Filed

Sep 15, 8:00 PM ET

Accepted

Sep 16, 7:31 PM ET

Size

17.6 KB

Accession

0001209191-21-056482

Insider Transaction Report

Form 4
Period: 2021-09-14
Transactions
  • Sale

    Common Stock

    2021-09-14$50.01/sh492$24,60383,522 total(indirect: By Spouse)
  • Sale

    Common Stock

    2021-09-15$48.71/sh30,000$1,461,20453,522 total(indirect: By Spouse)
  • Sale

    Common Stock

    2021-09-14$50.03/sh492$24,614587,731 total(indirect: By ERP Business Holdings, LP)
  • Sale

    Common Stock

    2021-09-16$50.01/sh346$17,30353,176 total(indirect: By Spouse)
  • Sale

    Common Stock

    2021-09-16$48.62/sh25,807$1,254,677510,731 total(indirect: By ERP Business Holdings, LP)
  • Sale

    Common Stock

    2021-09-15$48.97/sh24,193$1,184,690563,538 total(indirect: By ERP Business Holdings, LP)
  • Sale

    Common Stock

    2021-09-16$50.01/sh346$17,305510,385 total(indirect: By ERP Business Holdings, LP)
Footnotes (9)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.145. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F3]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021.
  • [F4]Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.
  • [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.25 to $49.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F6]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.80 to $49.32. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F7]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F8]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.50 to $49.165. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F9]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.045. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Issuer

C4 Therapeutics, Inc.

CIK 0001662579

Entity typeother

Related Parties

1
  • filerCIK 0001824823

Filing Metadata

Form type
4
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 7:31 PM ET
Size
17.6 KB